Patient preferences at ten years following initial diagnosis of atrial fibrillation: The Belgrade Atrial Fibrillation Study

Patient Preference and Adherence

Volumn 7, Issue , 2013, Pages 835-842

  Potpara, Tatjana S ^a,b   Polovina, Marija M ^b   Mujovic, Nebojsa M ^a,b   Kocijancic, Aleksandar M ^b   Lip, Gregory Y H ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Atrial fibrillation; Catheter ablation; Patient preferences; Symptoms; Treatment

Indexed keywords

ADULT; AGE; ARTICLE; COMORBIDITY; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PATIENT PREFERENCE; PROSPECTIVE STUDY; SEX DIFFERENCE; SINUS RHYTHM; SYMPTOM; WORK DISABILITY;

EID: 84883511916     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S50990     Document Type: Article

References (32)

1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-952.
2. Luderitz B, Jung W. Quality of life in patients with atrial fibrillation. Arch Intern Med. 2000;160:1749-1757.
3. Thrall G, Lane D, Carrol D, Lip GYH. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006;119:448. e1-e448. e19.
4. Wyse DG, Waldo AL, DiMarco JP, etal; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825-1833.
5. Van Gelder IC, Hagens VE, Bosker HA, etal; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347:1834-1840.
6. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet. 2000;356:1789-1794.
7. Carlsson J, Miketic S, Windeler J, etal; STAF Investigators. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol. 2003;41:1690-1696.
8. Testa L, Biondi-Zoccai GG, Dello Russo A, Belloci F, Andreotti F, Crea F. Rate-control vs rhythm-control in patients with atrial fibrillation: a meta-analysis. Eur Heart J. 2005;26:2000-2006.
9. Roy D, Talajic M, Nattel S, etal; Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358:2667-2677.
10. Corley SD, Epstein AE, DiMarco JP, etal; AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation. 2004;109:1509-1513.
11. Ionescu-Ittu R, Abrahamowicz M, Jackevicius CA, etal. Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. Arch Intern Med. 2012;172: 997-1004.
12. Kumagai K. Catheter ablation of atrial fibrillation State of the Art. Circ J. 2011;75:2305-2311.
13. Nault I, Miyazaki S, Forclaz A, etal. Drugs vs ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation. Eur Heart J. 2010;31:1046-1057.
14. Camm AJ, Lip GYH, De Caterina R, etal. 2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation. Eur Heart J. 2012;33:2719-2747.
15. Camm JA, Breithardt G, Crijns H, etal. Real-life observations of clinical outcomes with rhythm-and rate-control therapies for atrial fibrillation. RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J Am Coll Cardiol. 2011;58:493-501.
16. Aliot E, Brethardt G, Brugada J, et al; for the Atrial Fibrillation Awareness And Risk Education (AF AWARE) group [comprising the Atrial Fibrillation Association (AFA), the European Heart Rhythm Association (EHRA), Stroke Alliance for Europe (SAFE), and the World Heart Federation (WHF)]. An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular morbidity and mortality. Europace. 2010;12:626-633.
17. Potpara TS, Vasiljevic ZM, Vujisic-Tesic BD, etal. Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study. Chest. 2011;140:902-910.
18. Potpara TS, Stankovic GR, Beleslin BD, etal. A 12-year follow-up study of patients with newly-diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation Study. Chest. 2012;141:339-347.
19. Potpara TS, Marinkovic JM, Polovina MM, etal. Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade Atrial Fibrillation Study. Int J Cardiol. 2012;161:39-44.
20. Gronefeld GC, Lilienthal J, Kuck KH, Hohnloser SH. Pharmacological Intervention in Atrial Fibrillation (PIAF) Study investigators. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Eur Heart J. 2003;24:1430-1436.
21. Hagens VE, Ranchor AV, Van Sonderen E, etal; RACE Study Group. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol. 2004;43:241-247.
22. Jenkins LS, Brodsky M, Schron E, etal. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005;149:112-120.
23. Thrall G, Lip GY, Carroll D, Lane D. Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest. 2007;132:1259-1264.
24. Van Gelder IC, Haegeli LM, Brandes A, etal. Rationale and current perspective for early rhythm control therapy in atrial fibrillation. Europace. 2011;13:1517-1525.
25. Bunch TJ, Crandall BG, Weiss JP, etal. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22:839-845.
26. LinYJ, Chao TF, Tsao HM, etal. Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher. Europace. 2013;15: 676-684.
27. Population Health Research Institute. First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study). Available from: http://clinicaltrials.gov/show/NCT00392054. NLM identifier: NCT00392054. Accessed August 16, 2013.
28. Mayo Clinic. Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial (CABANA). Available from: http://clinicaltrials.gov/ct2/show/NCT00911508. NLM identifier: NCT00911508. Accessed August 16, 2013.
29. German Atrial Fibrillation Network. Early Treatment of Atrial Fibrillation for Stroke Prevention Trial (EAST). Available from: http://clinicaltrials.gov/show/NCT01288352. NLM identifier: NCT01288352. Accessed August 16, 2013.
30. Winkle RA, Mead RH, Engel G, Patrawala RA. Long-term results of atrial fibrillation ablation: the importance of all initial ablation failures undergoing a repeat ablation. Am Heart J. 2011;162:193-200.
31. Dagres N, Nieuwlaat R, Vardas PE, etal. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe. A report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol. 2007;49:572-577.
32. Xu W, Sun G, Lin Z, et al. Knowledge, attitude, and behavior in patients with atrial fibrillation undergoing radiofrequency catheter ablation. J Interv Card Electrophysiol. 2010;28:199-207.